Diep Van Nguyen | Disease | Best Researcher Award

Published on 11/07/202511/07/2025 by TOT Awards

Dr. Diep Van Nguyen | Disease | Best Researcher Award

Director at AVAC Vietnam Joint stock Company, Vietnam

Dr. Diep Van Nguyen is a visionary leader, scientist, and entrepreneur in veterinary vaccine development. He is currently the CEO and Director of the Center for Research and Development of Veterinary Vaccines at AVAC Viet Nam JSC, a leading company in animal health. With over 17 years of experience, Dr. Nguyen has spearheaded innovative vaccine projects, improved disease prevention strategies, and expanded global partnerships across Asia and Europe. He earned international recognition for his contributions to swine viral disease research and has published widely in high-impact journals. Dr. Nguyen holds a PhD from Miyazaki University (Japan) and has worked as a postdoctoral researcher at Kagoshima University. His leadership is grounded in science, innovation, and collaboration. Under his guidance, AVAC has become a cornerstone in Vietnam’s veterinary biotechnology sector. His contributions to ASF, PRRS, and PED vaccine research have positioned him as a global figure in veterinary immunology and biopharmaceutical innovation.

Professional Profile

ORCID

Education

Dr. Diep Van Nguyen began his academic journey at Vietnam National University of Agriculture, where he earned both his Doctor of Veterinary Medicine (2001–2006) and Master of Science in Veterinary Medicine (2007–2009). Pursuing advanced scientific training, he secured the prestigious Monbukagakusho Scholarship to complete his PhD in Veterinary Medicine at Miyazaki University, Japan (2013–2018). His doctoral studies focused on the molecular epidemiology of porcine epidemic diseases. Further honing his research expertise, Dr. Nguyen worked as a postdoctoral researcher at Kagoshima University (2018–2021), delving into gene-editing technologies and viral diagnostics. This internationally diverse education provided him with advanced insights into swine viral pathology and vaccine technology, laying the foundation for his impactful leadership in vaccine development. His academic background bridges Vietnamese clinical realities and Japanese research excellence, shaping his future innovations in veterinary medicine.

Work Experience

Dr. Diep Van Nguyen has cultivated a robust career that combines academia, research, and executive leadership. He began as a lecturer and researcher at the Vietnam National University of Agriculture, guiding students and participating in multiple international research collaborations. In 2021, he became the CEO of AVAC Viet Nam JSC, where he also leads the Center for Research and Development of Veterinary Vaccines. Under his leadership, AVAC launched pioneering products like AVAC ASF LIVE, PRRS LIVE, and LSD LIVE vaccines. He directed cross-border collaborations with international partners in the Philippines, India, Indonesia, and beyond. Dr. Nguyen’s work integrates regulatory compliance, scientific innovation, and commercial execution. He’s also contributed to internal process optimization and international patent submissions. His hands-on involvement in product development, strategic growth, and global networking has elevated Vietnam’s standing in veterinary pharmaceutical innovation.

🏆 Awards & Honors

Dr. Diep Van Nguyen has received notable national and international recognitions for his academic and scientific excellence. He was awarded the Best Student Award at the prestigious 7th International Symposium on Emerging and Re-emerging Pig Diseases (ISERPD 2015, Japan) for his contributions to swine viral epidemiology. From 2013 to 2018, he was a recipient of the Monbukagakusho Scholarship, Japan’s elite government-funded program for international scholars. In 2024, he received the distinguished Bao Son Prize, one of Vietnam’s top honors for scientific innovation and public service. These accolades reflect his deep commitment to combating viral diseases in livestock and his pioneering role in developing commercial vaccines. His recognition spans academic, industrial, and policy-making spheres, underscoring the impact of his research and leadership on both national food security and global animal health systems.

Research Focus

Dr. Nguyen’s research centers on swine viral diseases, particularly African Swine Fever (ASF), Porcine Reproductive and Respiratory Syndrome (PRRS), and Porcine Epidemic Diarrhea (PED). His core focus lies in the development of live-attenuated vaccines, viral genome sequencing, and molecular epidemiology. He is also actively advancing gene-editing techniques, specifically for creating robust viral vaccine platforms. His contributions include leading the creation of immortalized cell lines (e.g., DMAC) for effective virus propagation, submitting patents for novel vaccine strains, and evaluating cross-protection efficacy. His research integrates field-based outbreak data with laboratory innovations to develop scalable solutions for endemic and emerging diseases. Dr. Nguyen’s long-term vision is to provide affordable, effective, and globally deployable veterinary vaccines while maintaining strong regulatory standards and cross-national research collaborations.

Skills

Dr. Diep Van Nguyen possesses an exceptional mix of scientific, managerial, and entrepreneurial skills. His technical expertise includes gene-editing, molecular diagnostics, vaccine strain development, and cell line engineering. He is adept in strategic planning, product innovation, R&D leadership, and vaccine commercialization. As CEO, he oversees financial planning, regulatory compliance, market analysis, and strategic partnerships with global veterinary health companies. His communication fluency in English and intermediate proficiency in Japanese enable him to collaborate across borders effectively. He also leads cross-functional teams and drives innovation in disease prevention solutions. His contributions in regulatory navigation, grant acquisition, scientific publishing, and international presentations make him a sought-after expert in the veterinary vaccine industry. Additionally, Dr. Nguyen’s strength lies in uniting academic rigor with real-world applications, driving impactful outcomes in livestock health and food security.

Conclusion

Dr. Diep Van Nguyen is exceptionally suitable for the Research for Best Researcher Award. His visionary leadership, coupled with groundbreaking research and successful commercialization of vaccines, makes him a model scientist bridging academic excellence with real-world impact. His innovations in combating African Swine Fever and other major livestock diseases contribute to both regional food security and global animal health. A recognized scientific leader in Southeast Asia, Dr. Nguyen is not only advancing knowledge but also transforming veterinary public health systems.

Publications to Noted

Title: Establishment of an Immortalized Porcine Alveolar Macrophage Cell Line That Supports Efficient Replication of Porcine Reproductive and Respiratory Syndrome Viruses

🧑‍🤝‍🧑 Authors: Diep NV, Hayakawa-Sugaya Y, Ishikawa S, Kawaguchi H, Suda Y, Esaki M, Ozawa M

📅 Year: 2024

📊 Citations: 2

Title: Genotype II Live-Attenuated ASFV Vaccine Strains Unable to Completely Protect Pigs against the Emerging Recombinant ASFV Genotype I/II Strain in Vietnam

🧑‍🤝‍🧑 Authors: Diep NV, Duc NV, Ngoc NT, Dang VX, Tiep TN, Nguyen VD, Le VP

📅 Year: 2024

📊 Citations: 4

Title: Multiple variants of African swine fever virus circulating in Vietnam

🧑‍🤝‍🧑 Authors: Nguyen VT, Cho KH, Mai NTA, Park JY, Trinh TBN, Jang MK, Le VP

📅 Year: 2022

📊 Citations: 25

Title: Newly-designed primer pairs for the detection of type 2 porcine reproductive and respiratory syndrome virus genes

🧑‍🤝‍🧑 Authors: Fukunaga W, Hayakawa-Sugaya Y, Koike F, Van Diep N, Kojima I, Yoshida Y, Ozawa M

📅 Year: 2021

📊 Citations: 12

Title: Pathology of the outbreak of subgenotype 2.5 classical swine fever virus in northern Vietnam

🧑‍🤝‍🧑 Authors: Izzati UZ, Hoa NT, Lan NT, Diep NV, Fuke N, Hirai T, Yamaguchi R

📅 Year: 2021

📊 Citations: 17

Title: O/SEA/Mya-98 lineage foot-and-mouth disease virus was responsible for an extensive epidemic in Vietnam

🧑‍🤝‍🧑 Authors: Van Diep N, Ngoc TTB, Hoa LQ, Nga BTT, Kang B, Oh J, Le VP

📅 Year: 2020

📊 Citations: 9

Title: New tropisms of PEDV in pigs naturally coinfected with variants bearing deletions in the spike protein

🧑‍🤝‍🧑 Authors: Van Diep N, Choijookhuu N, Fuke N, Myint O, Izzati UZ, Suwanruengsri M, Yamaguchi R

📅 Year: 2020

📊 Citations: 32

Title: Severe degenerative changes in cryptorchid testes in Japanese black cattle

🧑‍🤝‍🧑 Authors: Fuke N, Kitahara G, Ito S, Van Diep N, Ping Teh AP, Izzati UZ, Yamaguchi R

📅 Year: 2020

📊 Citations: 14

Title: Development of indirect ELISA for detection of PEDV-specific antibodies (IgG) in naturally infected pigs

🧑‍🤝‍🧑 Authors: Myint O, Yoshida A, Sekiguchi S, Van Diep N, Fuke N, Izzati UZ, Yamaguchi R

📅 Year: 2019

📊 Citations: 28

Doutchi Mahamadou | Infectiology | Distinguished Scientist Award

Published on 03/07/202503/07/2025 by TOT Awards

Prof. Doutchi Mahamadou | Infectiologie | Distinguished Scientist Award

Head of Infectious and Tropical Diseases Department at André Salifou University, Niger

Dr. Mahamadou Elh Mahamane Doutchi is a seasoned infectious disease specialist and public health expert from Niger, serving as Associate Professor at the University of Zinder since 2022. He is the Deputy Head of the Department of Medicine and Medical Specialties and leads the Infectious Diseases Department at Zinder National Hospital. With over two decades of experience, he has made significant contributions in clinical care, medical education, and epidemic response. Dr. Doutchi has actively participated in managing outbreaks such as Rift Valley Fever and COVID-19 and contributed to malaria chemoprevention initiatives in Niger and Mali. As President of the Nigerian Society of Infectious Pathology (SONIPI), he plays a crucial role in shaping national infectious disease policy. His academic contributions include over 44 publications, three book chapters, and the supervision of numerous theses. Passionate about health system strengthening, he continues to influence both practice and policy through his research and teaching.

Professional Profile

ORCID

Education

Dr. Doutchi holds a Doctorate in General Medicine from the University Abdou Moumouni (2008), a Master’s in Public Health with a focus on Health Systems Engineering from the University of Marseille (2012), and multiple diplomas in infectious diseases. His specialized training includes a DFMS in Clinical and Biological Infectious Diseases from Marseille (2013), a DES in Infectious Diseases from Cheikh Anta Diop University (2014), and an inter-university diploma in Antibiology and Antibiotherapy from INSSA Burkina Faso. He also obtained his baccalaureate in Mathematics and Physical Sciences from Kouara High School in 1997. Between 2004 and 2024, he completed over 15 professional courses and internships to stay updated on emerging medical challenges. His multidisciplinary educational background, spanning medicine, public health, and microbiology, underpins his holistic approach to disease prevention, health promotion, and clinical management in both academic and field settings.

Work Experience

Dr. Doutchi’s extensive professional journey includes his ongoing role as a teaching-researcher at the University of Zinder since 2016, where he delivers over 170 hours of lectures and supervises 500 hours of clinical training yearly. His prior roles span multiple countries and organizations, including MSF and ALIMA, where he coordinated research and emergency responses in Niger, Mali, Nigeria, Chad, Senegal, and Côte d’Ivoire. He led projects on malaria chemoprevention, managed outbreaks (Rift Valley Fever, Lassa Fever), and supported malnutrition initiatives. He also interned at Hôpital La Conception in Marseille in 2013 and worked with MSF Switzerland (2008–2009). His work involves planning, implementation, training, supervision, and data analysis. He has demonstrated leadership in both crisis and stable environments, integrating research with real-time healthcare delivery. He remains a key figure in infectious disease management and public health intervention across Francophone Africa.

🏆 Awards & Honors

Dr. Doutchi has received wide recognition for his leadership in infectious disease management and health system strengthening. As President of the Nigerian Society of Infectious Pathology (SONIPI) since 2023, he has been instrumental in promoting research collaboration and policy formulation. He is also an active member of five prestigious medical societies, including the Société de Pathologie Infectieuse de Langue Française (SPILF) and the Société de Pathologie Exotique. His scientific presentations at key conferences such as the Journées Nationales d’Infectiologie (Saint-Malo) and CERMES (Niamey) have garnered attention for their relevance and rigor. Notably, his efforts in epidemic preparedness, malaria vaccine research, and community health programs have led to local and regional commendations, especially for his work during the COVID-19 pandemic and the Rift Valley Fever outbreak. His prolific academic output, mentorship, and cross-border collaboration reinforce his standing as a respected leader in global health.

Research Focus

Dr. Doutchi’s research spans malaria control, antimicrobial resistance, viral outbreaks, and public health preparedness. As co-investigator on multiple studies, he has addressed pressing health issues in West Africa, particularly the clinical and epidemiological characteristics of malaria, Rift Valley Fever, Lassa Fever, and HIV/AIDS. His interests lie in the operationalization of health interventions, such as seasonal malaria chemoprevention, vaccine campaigns, and outbreak response strategies. He also investigates antimicrobial usage patterns, aiming to curb resistance through education and policy reforms. His commitment to translational research ensures that findings are implemented in real-world settings. With over 44 peer-reviewed publications and 25 conference communications, Dr. Doutchi advocates for evidence-based practices tailored to low-resource environments. His work bridges academia and field operations, enhancing health system responsiveness through scientific innovation and cross-disciplinary collaboration.

Skills

Dr. Doutchi possesses a robust blend of clinical, academic, and public health skills. He excels in managing infectious disease cases, supervising clinical training, and designing university curricula. His capabilities include project planning and budget oversight, epidemiological and nutritional survey execution, and advanced data analysis using statistical software. A skilled communicator and educator, he has trained dozens of medical and paramedical staff and directed numerous health campaigns. His research expertise encompasses proposal writing, scientific publishing, and thesis supervision. His familiarity with international NGOs, such as ALIMA and MSF, has honed his ability to manage humanitarian crises and coordinate multidisciplinary teams. Notably, his ethical decision-making, cross-cultural sensitivity, and initiative-driven leadership have enabled him to navigate complex health emergencies effectively. He is also well-versed in inspection protocols, stakeholder engagement, and the development of innovative pedagogical tools for medical education.

Conclusion

Dr. Mahamadou Doutchi is highly suitable for the Research for Distinguished Scientist Award, particularly for his lifelong commitment to combating infectious diseases, developing public health infrastructure, and educating future medical professionals. His diverse experience across clinical, academic, and NGO sectors, combined with his leadership in handling health emergencies and mentoring junior researchers, exemplifies the criteria of a distinguished scientist with real-world impact.

Publications to Noted

First Cases of Dengue Fever Confirmed in the National Hospitals of Zinder and Niamey
Authors: Doutchi M., et al.
Journal: Case Reports in Infectious Diseases
Year: 2025 (Jan)

The resurgence of diphtheria in Zinder, Niger**
Authors: Doutchi M., Bara Abdoul‑Aziz A., Lamine M. M., Diongolé H., et al.
Journal: Infectious Diseases Now
Year: 2024 (Dec)

Circulation of Non‑falciparum Species in Niger: Implications for Malaria Diagnosis
Authors: Doutchi M., et al.
Journal: Open Forum Infectious Diseases
Year: 2024 (Aug 30)

Presentation and outcomes of Lassa fever in children in Nigeria: a prospective cohort study (LASCOPE)
Authors: Doutchi M., et al.
Journal: Journal of the Pediatric Infectious Diseases Society
Year: 2024 (Aug)

Inducible clindamycin resistance among clinical Gram‑positive cocci in a tertiary hospital in Niger Republic
Authors: Doutchi M.
Preprint: 2024 (Jun)

Health transformation toward universal healthcare coverage amidst conflict: examining the impact of international cooperation in Niger
Authors: Doutchi M.
Journal: Frontiers in Public Health
Year: 2024 (Mar)

Urinary Schistosomiasis in the Urban Community of Zinder (Niger): The Permanent Pond of In’birgui, an Epidemic Focus
Authors: Doutchi M.
Journal: Iranian Journal of Parasitology
Year: 2024 (Jan)

Fractional dosing to improve vaccination coverage, vaccine hesitancy, and cost‑effectiveness in Africa: a systematic review
Authors: Doutchi M.
Preprint: 2023 (Aug)

Metagenomic Direct Diagnosis of Polymicrobial Community‑Acquired Meningoencephalitis in Niger: A Case Report
Authors: Doutchi M.
Preprint: 2023 (Aug)

Missed opportunities to develop childhood cancer programmes in Africa
Authors: Doutchi M.
Journal: The Lancet Child & Adolescent Health
Year: 2023 (Jul)

Hong Yu | Bacterial Infection | Best Researcher Award

Published on 30/06/202530/06/2025 by TOT Awards

Dr. Hong Yu | Bacterial Infection | Best Researcher Award

Research Associate Professor at Medical University of South Carolina, United States

Dr. Hong Yu, M.D., is a distinguished Research Associate Professor at the Medical University of South Carolina (MUSC), specializing in biomedical and community health sciences. With a solid foundation in pathology and translational research, Dr. Yu has contributed significantly to understanding inflammatory diseases, bone regeneration, and immune signaling in oral health. Her research has garnered major NIH funding and has been published in high-impact journals. As a dedicated academician, Dr. Yu mentors emerging scholars and plays an active role in editorial services, scientific societies, and university committees. Her leadership roles at MUSC, including Director and Co-Director of key lab facilities, underscore her commitment to advancing scientific infrastructure. Recognized for her collaborative spirit and scientific rigor, Dr. Yu continues to drive innovation in aging, oral immunology, and metabolic disease research, positively impacting both clinical and research communities.

Professional Profile

ORCID

Education

Dr. Yu earned her M.D. degree from Beijing Medical University (1990–1994), followed by a pathology residency at the People’s Hospital of the same university (1990–1995). She further expanded her international exposure as an Ivu Wu Fellow at Queen Mary Hospital, University of Hong Kong (1998–1999). Her postdoctoral research trajectory in the United States included appointments at the Medical University of South Carolina in the Departments of Microbiology & Immunology, Pediatrics, and Oral Health Sciences (2000–2009). These formative years established her expertise in immunology, oral pathology, and translational biomedical research. With training spanning clinical practice and laboratory research, Dr. Yu possesses a rare combination of medical insight and bench-side innovation, enabling her to explore disease mechanisms and develop novel therapeutic approaches.

Work Experience

Dr. Yu’s career spans clinical, research, and academic leadership roles. Clinically, she served as a Resident and later an Attending Physician in Pathology at the People’s Hospital in Beijing (1990–2000). Transitioning to research, she held multiple postdoctoral positions at MUSC (2000–2009). She was appointed Research Assistant Professor (2011–2017) and subsequently Research Associate Professor in the Department of Oral Health Sciences (2017–2023). Since 2023, she has served as Research Associate Professor in the Department of Biomedical and Community Health Sciences. Her administrative contributions include leading preclinical and laboratory cores within the Center for Oral Health Research. As an educator, she teaches dental biochemistry and mentors pre-doctoral and summer students. Her multifaceted experience showcases her versatility in medical science, mentoring, and institutional development.

🏆 Awards & Honors

Dr. Yu has earned multiple NIH grants, including prestigious R21 and R01 awards for studies on periodontitis, immune signaling, and aging. Her Principal Investigator roles reflect her leadership in advancing oral and systemic health. She received internal honors like the Center for Healthy Aging Pilot Grant and was trusted with co-investigator duties on high-budget collaborative research. She has been invited to serve on the Editorial Review Boards of journals such as Cells, Journal of Dentistry and Oral Biology, and others, recognizing her expert insights. She also actively serves as a peer reviewer for more than 15 top-tier journals including Scientific Reports and Journal of Dental Research. Her selection as a judge at several MUSC research events underscores her status as a thought leader in her field.

Research Focus

Dr. Yu’s research centers on immune signaling in oral and systemic inflammatory diseases, with emphasis on sphingosine-1-phosphate receptors, CD38 signaling, and bone metabolism. Her work dissects the complex molecular pathways influencing osteoblastogenesis, osteoclastogenesis, and cytokine regulation, especially in conditions like periodontitis, metabolic syndrome, and aging. Her studies integrate oral microbiology, lipid signaling, and immunopathology to develop novel therapeutic interventions for bone regeneration and chronic oral infections. Through animal models and molecular biology tools, she investigates how systemic conditions exacerbate oral diseases, laying the foundation for cross-disciplinary treatment strategies. As a co-investigator on siRNA delivery systems for oral cancer, her focus also extends to molecular therapy and nanocarrier systems. Dr. Yu’s translational science approach bridges basic science and clinical applications, improving outcomes in oral and systemic health.

Conclusion

Dr. Hong Yu is highly suitable for the Research for Best Researcher Award. Her portfolio reflects the hallmarks of a top-tier scientist: sustained research productivity, leadership in biomedical science, mentorship, and service to the academic community. Her future-facing projects on immune responses in aging and chronic diseases showcase not only scientific excellence but also critical relevance to public health. Recognition through this award would not only honor her past contributions but encourage the continued evolution of her impactful research.

Publications to Noted

CD38 Inhibitor 78c Attenuates Pro‑Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages
Authors: William Lory; Nityananda Chowdhury, PhD; Bridgette Wellslager; Subramanya Pandruvada; Yan Huang; Özlem Yilmaz; Hong Yu
Journal: Cells
Year: 2024 (Nov)

GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome‑Exacerbated Periodontitis in Mice
Authors: Yanchun Li; Hong Yu; Maria F. Lopes-Virella; Yan Huang
Journal: International Journal of Molecular Sciences
Year: 2024 (Sep)

The Presence of Periodontitis Exacerbates Non‑Alcoholic Fatty Liver Disease via Sphingolipid Metabolism‑Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome
Authors: Zhongyang Lu; Yanchun Li; Nityananda Chowdhury, PhD; Hong Yu; Wing-Kin Syn; Maria Lopes-Virella; Özlem Yilmaz; Yan Huang
Journal: International Journal of Molecular Sciences
Year: 2023 (May)

Inhibition of Sphingosine‑1‑Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis
Authors: William Lory; Bridgette Wellslager; Chao Sun; Özlem Yilmaz; Hong Yu
Journal: International Journal of Molecular Sciences
Year: 2023 (Feb)

Inhibition of Sphingosine‑1‑Phosphate Receptor 2 by JTE013 Promoted Osteogenesis via Vesicle Trafficking, Wnt/Ca²⁺, and BMP/Smad Signaling
Authors: Simon Lin; Subramanya Pandruvada; Hong Yu
Journal: International Journal of Molecular Sciences
Year: 2021 (Nov)

Targeting S1PRs as a Therapeutic Strategy for Inflammatory Bone Loss Diseases—Beyond Regulating S1P Signaling
Author: Hong Yu
Journal: International Journal of Molecular Sciences
Year: 2021 (Apr)

Sphingosine‑1‑Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption
Authors: Li‑Chien Hsu; Sakamuri V. Reddy; Özlem Yilmaz; Hong Yu
Journal: Cells
Year: 2019 (Jan)

Tom Mammone | Biology | Best Researcher Award

Published on 27/03/202527/03/2025 by TOT Awards

Dr.Tom Mammone | Biology | Best Researcher Award

Senior Research Scientist at Estee. Lauder, United States.

Thomas Mammone is a distinguished researcher in dermatology and skin biology, with extensive contributions to understanding cellular responses to environmental stressors. His work has significantly advanced knowledge of oxidative stress, DNA repair, and protective mechanisms against UV radiation. Mammone has collaborated with leading scientists in dermatological research, focusing on novel skincare and therapeutic applications. His publications cover a broad spectrum of topics, from the effects of green tea phenols on UVB-induced DNA damage to the role of histamine receptors in sebocytes. With a deep interest in cellular aging, inflammation, and protective biomolecules, he has contributed to groundbreaking skincare formulations. His extensive experience in laboratory research, coupled with expertise in experimental dermatology, has positioned him as a leader in the field. Throughout his career, Mammone has worked with prestigious institutions, co-authoring numerous peer-reviewed articles that continue to influence dermatological science. His work remains a cornerstone of modern skin research.

professional profiles

Scopus

Education

Thomas Mammone earned his academic credentials in biological sciences and dermatology-related research from renowned institutions. His foundational studies focused on cellular biology, molecular mechanisms of skin aging, and oxidative stress responses. He pursued advanced education in biochemistry, skin pharmacology, and immunology, which laid the groundwork for his extensive research on epidermal keratinocytes, fibroblasts, and antioxidant mechanisms. Through his academic training, Mammone developed expertise in dermatological cell biology, investigating key pathways in inflammation, DNA repair, and skin barrier function. His education provided a strong background in experimental techniques, allowing him to explore how environmental stressors like UV radiation impact skin cells. With a firm grasp of biochemical pathways, his studies emphasized translational research, bridging the gap between laboratory findings and real-world dermatological applications. His educational journey has been instrumental in shaping his research focus on developing innovative skincare solutions and therapeutic interventions.

work Experience

Thomas Mammone has accumulated vast experience in dermatological research, focusing on cellular responses to environmental stressors, oxidative damage, and skin protection. He has held research positions in renowned laboratories, contributing to groundbreaking studies on UV protection, inflammation modulation, and DNA repair enhancement. His expertise spans in vitro and in vivo experimental dermatology, employing advanced techniques to investigate keratinocyte and fibroblast behavior under stress conditions. Throughout his career, Mammone has worked in both academic and corporate research settings, bridging scientific discoveries with skincare innovations. He has collaborated with interdisciplinary teams, integrating dermatological science with cosmetic formulations. His work has led to the development of novel skincare solutions that enhance cellular protection against environmental damage. With an extensive portfolio of peer-reviewed publications, he has established himself as a leader in the field of dermatological cell biology, continuously pushing the boundaries of skin research and therapeutic advancements.

Research Focus

Thomas Mammone’s research focuses on skin biology, cellular responses to environmental stressors, and innovative dermatological interventions. His work explores the mechanisms of oxidative stress, inflammation, and DNA damage repair in keratinocytes and fibroblasts. He has conducted extensive studies on the effects of UV radiation on human skin, examining protective strategies such as antioxidants, DNA repair enzymes, and novel pharmacological agents. His research also investigates the role of histamine receptors, osmotic stress responses, and apoptosis in skin aging and pathology. Mammone is particularly interested in developing cosmeceutical formulations that enhance skin protection and rejuvenation. His work integrates molecular biology, pharmacology, and dermatology, providing a comprehensive understanding of skin defense mechanisms. By bridging fundamental science with practical applications, his research has led to groundbreaking skincare innovations that improve skin resilience against environmental damage, making significant contributions to both scientific knowledge and consumer skincare solutions.

Awards & Honors🏆

Thomas Mammone has received multiple recognitions for his contributions to dermatological research, particularly in the areas of oxidative stress, DNA repair, and UV protection. His work on cellular responses to environmental stressors has been honored by prestigious scientific organizations. Mammone has been invited as a keynote speaker at dermatology and skincare conferences worldwide, highlighting his expertise in skin biology and inflammation modulation. His research on antioxidants in skincare has earned industry accolades, leading to commercial applications in cosmeceuticals. He has also been recognized for his collaborative efforts with renowned scientists in dermatological research. His pioneering studies on the protective effects of salicylic acid, green tea phenols, and DNA repair enzymes in skincare have influenced modern dermatology. Mammone’s dedication to scientific excellence and translational research has positioned him as a thought leader in skin health, earning him accolades from both academic and industry professionals.

Conclusion

Self-assembly of short biopeptides onto skin tissue components studied using QCM-D

Authors: N.S. Murthy, N. Sanjeeva, E. Tavasoli, Elham, T. Mammone, Thomas, N. Karaman-Jurukovska, Nevena

Journal: International Journal of Cosmetic Science

Year: 2025

Citations: 0

Noninvasive Monitoring of Palmitoyl Hexapeptide-12 in Human Skin Layers: Mechanical Interaction with Skin Components and Its Potential Skincare Benefits

Authors: C. Ligorio, Cosimo, E. Tavasoli, Elham, N. Karaman-Jurukovska, Nevena, T. Mammone, Thomas, Á. Mata, Álvaro

Journal: ACS Applied Bio Materials

Year: 2025

Citations: 0

S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis

Authors: Y. Niki, Yoko, N. Adachi, Naoko, M. Fukata, Masaki, N. Saito, Naoaki, T. Ueyama, Takehiko

Journal: Journal of Investigative Dermatology

Year: 2023

Citations: 10

Post-Inflammatory Hyperpigmentation in Dark Skin: Molecular Mechanism and Skincare Implications

Authors: E. Markiewicz, Ewa, N. Karaman-Jurukovska, Nevena, T. Mammone, Thomas, O.C. Idowu, Olusola Clement

Journal: [No source information available]

Year: [Unknown]

Citations: 32

Hanseob Shin | Antimicrobial | Best Researcher Award

Published on 06/03/202506/03/2025 by TOT Awards

Dr. HanseobShin | Antimicrobial | Best Researcher Award

Postdoc scholar at University of iowa,United States

Dr. Hanseob Shin is a dedicated environmental microbiologist specializing in tracking environmental contamination, microbial ecology, and antimicrobial resistance in water systems. As a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, he actively investigates the fate and transport of antibiotic-resistant bacteria in various aquatic environments. His research applies CRISPR spacerome analysis and microbial source tracking to understand the dynamics of contamination sources. With extensive experience in environmental microbiology, Dr. Shin has contributed significantly to identifying antibiotic-resistant genes in wastewater and river systems, improving public health risk assessment. He has authored numerous scientific publications in prestigious journals and actively participates in national and international conferences. Through his research, he aims to develop innovative solutions for mitigating microbial contamination in natural and engineered water systems, promoting environmental sustainability and health protection.

Professional Profile

Scopus Profile

ORCID

Education 🎓

Dr. Hanseob Shin obtained his Ph.D. in Earth Sciences and Environmental Engineering from the Gwangju Institute of Science and Technology, South Korea, in 2022. His doctoral research focused on long-term monitoring of antibiotic resistance genes and bacteria in rivers and wastewater treatment plants, providing valuable insights into microbial contamination dynamics. Before his Ph.D., he earned a Bachelor of Science in Molecular Biotechnology from Chonnam National University in 2015, where he developed a strong foundation in microbial genetics and biotechnology. His academic journey has been marked by a keen interest in microbial ecology, antibiotic resistance, and environmental health. Dr. Shin’s education has equipped him with expertise in advanced microbiological techniques, including metagenomics, CRISPR engineering, and microbial source tracking. His interdisciplinary training bridges environmental science and molecular biotechnology, enabling him to address pressing challenges in water quality management and public health protection.

Work Experience 💼

Dr. Hanseob Shin has accumulated extensive experience in environmental microbiology and microbial source tracking. Since 2022, he has been a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, where he investigates antimicrobial resistance in water systems. Prior to this, he worked as a Postdoctoral Research Associate at the Gwangju Institute of Science and Technology, contributing to research on microbial contamination in wastewater treatment plants. His work has involved the application of molecular and genomic tools to study antibiotic-resistant bacteria in environmental settings. Additionally, he has collaborated with government agencies and research institutions to assess microbial contamination in agricultural and urban water sources. Through his academic and research roles, Dr. Shin has developed a strong expertise in microbial ecology, CRISPR-based bacterial identification, and the environmental impact of antibiotic resistance genes.

Research Interests 🔬

Dr. Hanseob Shin’s research is centered on environmental microbiology, microbial ecology, and the fate and transport of antimicrobial resistance in water systems. He investigates the spread of antibiotic-resistant bacteria in aquatic environments, including wastewater treatment plants, rivers, and agricultural runoff. His work utilizes CRISPR spacerome analysis for strain-level bacterial identification and microbial source tracking to trace contamination origins. Dr. Shin also explores the role of core antibiotic resistance genes as indicators of pollution in wastewater and natural water bodies. His studies contribute to improving strategies for mitigating microbial risks in water systems. Additionally, he examines the genetic diversity of antibiotic-resistant bacteria, aiming to understand their persistence and potential health risks. His research has practical applications in public health, environmental policy, and water treatment technologies, promoting safer water resources and sustainable environmental management.

Awards & Achievements 🏆

Dr. Hanseob Shin has received recognition for his outstanding research contributions in environmental microbiology. In 2022, he was awarded the Outstanding Best Poster Award at the International Symposium and Annual Meeting of the KSABC for his work on antibiotic resistance genes in effluent and receiving water. His research projects have secured significant funding, including a $300,000 grant from the Chicago Community Trust for studying antibiotic-resistant bacteria in Iowa’s concentrated animal feeding operations (CAFOs). He has also received substantial research grants from the Rural Development Administration and the Korea Environmental Industry & Technology Institute for projects related to wastewater treatment and antibiotic-resistant organisms. His contributions as a peer reviewer for high-impact journals further highlight his expertise in the field. Dr. Shin’s accolades reflect his dedication to advancing scientific knowledge on microbial contamination and public health.

Conclusion

Dr. Hanseob Shin is a strong candidate for the Best Researcher Award due to his impactful contributions to environmental microbiology, antibiotic resistance, and microbial tracking. His extensive publication record, research funding, and conference presentations position him as an emerging leader in his field. While he could enhance his profile by expanding his independent research leadership and mentorship roles, his current achievements make him a highly competitive nominee for this prestigious award.

Top Noted Publications 📚

Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

Authors: Not specified

Year: 2022

Citations: Not specified

Prevalence and Characterization of CRISPR Locus 2.1 Spacers in Escherichia coli Isolates Obtained from Feces of Animals and Humans

Authors: Not specified

Year: 2023

Citations: Not specified

Resistome Study in Aquatic Environments

Authors: Not specified

Year: 2023

Citations: Not specified

Dynamics of Genotypic and Phenotypic Antibiotic Resistance in a Conventional Wastewater Treatment Plant in 2 Years

Authors: Not specified

Year: 2022

Citations: Not specified

Geographical distribution and genetic diversity of Bradyrhizobium spp. isolated from Korean soybean root nodules

Authors: Not specified

Year: 2022

Citations: Not specified

Higher abundance of core antimicrobial resistant genes in effluent from wastewater treatment plants

Authors: Not specified

Year: 2022

Citations: Not specified

Phylogenetic diversity and spatiotemporal dynamics of bacterial and microeukaryotic plankton communities in Gwangyang Bay of the Korean Peninsula

Authors: Not specified

Year: 2022

Citations: Not specified

Emergence of High Level Carbapenem and Extensively Drug Resistant Escherichia coli ST746 Producing NDM-5 in Influent of Wastewater Treatment Plant, Seoul, South Korea

Authors: Not specified

Year: 2021

Citations: Not specified

Metagenomic exploration of antibiotic resistome in treated wastewater effluents and their receiving water

Authors: Not specified

Year: 2021

Citations: Not specified

High genetic diversity of Vibrio parahaemolyticus isolated from tidal water and mud of southern coast of South Korea

Authors: Not specified

Year: 2019

Citations: Not specified

Metagenomic analysis reveals the prevalence and persistence of antibiotic- and heavy metal-resistance genes in wastewater treatment plant

Authors: Not specified

Year: 2018

Citations: Not specified

Tanushree Gupta | Microbiology | Women Researcher Award

Published on 20/11/202420/11/2024 by TOT Awards

Dr. Tanushree Gupta | Microbiology | Women Researcher Award

Senior Scientist at AgResearch, New Zealand

Dr. Tanushree Barua Gupta is a Senior Scientist at AgResearch Ltd, New Zealand, with over 15 years of experience in the field of microbiology and food safety. She holds a Doctorate in Medical Microbiology and specializes in the identification of novel antimicrobials, the commercialization of lab-based innovations, and the development of advanced diagnostics for the food and agriculture sectors. Her research focuses on areas such as biocontrol, food spoilage, and the application of plant-based antimicrobials. Dr. Gupta has made significant contributions to improving the safety and shelf life of food products, with numerous publications and patents in the area of microbiology and food safety.

professional profiles

ORCID

Education

Dr. Gupta holds a Doctorate of Philosophy (PhD) in Medical Microbiology from the Vallabhbhai Patel Chest Institute, University of Delhi, India, completed in 2010. Her doctoral thesis, “Studies on detection and characterization of AmpC beta-lactamases in clinical isolates of Klebsiella spp. and Escherichia coli,” contributed significantly to the field of microbiology. She completed her Master of Science in Microbial and Food Technology from Punjabi University, Patiala, India, in 2004, where she further honed her expertise in the microbiological aspects of food and dairy. Dr. Gupta’s strong academic foundation supports her innovative research in antimicrobial agents, food safety, and biotechnology.

work Experience

Dr. Gupta’s research career spans over 15 years, beginning with her position as a Junior Research Fellow at the National Dairy Research Institute in India (2005). She has since served as a Postdoctoral Fellow at AgResearch (2010-2011) and then as a Senior Research Scientist at AgResearch Ltd, New Zealand, from 2011 onwards. Her research has primarily focused on microbial contamination, food spoilage bacteria, and the development of novel antimicrobial agents, particularly those isolated from farm environments. Dr. Gupta has collaborated internationally on projects aimed at improving food safety, with a particular emphasis on dairy and meat products. She works closely with dairy companies to enhance the shelf life of products and contributes to advancing biotechnology through the commercialization of her research. Her expertise also extends to the application of CRISPR technology in pathogen detection and the use of plant-based antimicrobials for food preservation.

Awards and honors

Dr. Tanushree Gupta has received multiple prestigious awards recognizing her contributions to the field of microbiology and food safety. In 2024, she was selected as a finalist for the AgriFutures Grow Catalyst Program for women in agriculture, a distinction she holds as the only New Zealand-based researcher. She was also honored with the Basil Jarvis Prize in Food Safety by Applied Microbiology International (2022). Dr. Gupta has received the KiwiNet Emerging Innovation Award (2022), the Humphrey M. Russel Award (2022), and the Young Scientist Award by FEMS (2016). Additionally, she was recognized as the Global Ambassador for Oceania Pacific of Applied Microbiology International in 2023. Her other accolades include being awarded the Senior Research Fellowship from the Indian Council of Medical Research and several travel grants to attend leading international conferences, showcasing her continuous global impact in the field of microbial research and food safety.

Research Focus

Skills

Dr. Gupta possesses an extensive skill set in microbiological research, specializing in the detection and characterization of pathogens in food systems. She is adept at applying advanced molecular techniques, such as PCR, real-time PCR, and CRISPR, for bacterial identification and diagnostics. Her expertise includes isolating and identifying novel antimicrobial agents from environmental sources, including farm environments. Dr. Gupta is proficient in the use of bioinformatics tools and multi-omics approaches for studying microbial communities and their interactions in food and farm environments. She has advanced knowledge in biocontrol methods, using bioactive compounds from bacteria to combat pathogens. Additionally, Dr. Gupta’s skill set extends to applying plant-based antimicrobials to enhance food preservation. With a strong background in commercializing scientific innovations, she plays an active role in translating laboratory research into practical applications, especially in the dairy and meat industries, to enhance food safety and shelf life.

Conclusion

Dr. Tanushree Barua Gupta is an outstanding candidate for the Women Researcher Award. Her innovative research, commitment to the commercialization of scientific discoveries, and recognition in the global scientific community make her a leader in the fields of microbiology, food safety, and applied research. She has not only made significant strides in improving food safety but also contributed to enhancing the sustainability and safety of agricultural practices. Dr. Gupta exemplifies the qualities of a trailblazer and role model for women in research and science.

Publications to Noted

Impact of Ultra-High-Pressure Homogenisation on the Inactivation of Bacillus pumilus and Bacillus subtilis Spores in Sheep and Cow Milk

Authors: Antony Anila, Aswathi Soni, Linda M. Samuelsson, Mike Weeks, Meng Wai Woo, Siew-Young Quek, Mohammed Farid, and Tanushree Gupta

Citations: 0 (since it’s from October 2024)

Year: 2024

DOI: 10.3390/foods13213452